A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...

On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...

Here’s what experts say you should know about DIM, "good" estrogens and the future of hormone support in midlife and beyond. That ‘Natural’ Supplement Might Be Messing With Your Hormones DIM is a ...

A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...

“The role of testosterone is just a lesson in gender bias,” says Kelly Casperson, MD, a urologist. “Because 100 percent of ...

Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...

Overall, this suggests that the cumulative risk of breast cancer before age 55 for women taking estrogen/progestin is about 4.5%, compared with 4.1% among women who never used hormone therapy and 3.6% ...

Hormone therapy can be used to boost hormone levels and relieve menopause symptoms, which typically last an average of five years but can be as long as 10 years.

Hormone therapy — also called gender-affirming hormone therapy (GAHT), hormone replacement therapy (HRT), transgender hormone therapy (THT), estrogen hormone therapy (ERT) ...